Dr Richard M Harrell, MD | |
1455 E Bert Kouns Loop, Shreveport, LA 71105-5634 | |
(318) 798-4623 | |
(318) 798-4628 |
Full Name | Dr Richard M Harrell |
---|---|
Gender | Male |
Speciality | Sports Medicine |
Experience | 37 Years |
Location | 1455 E Bert Kouns Loop, Shreveport, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346244209 | NPI | - | NPPES |
1370959 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 019429 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ochsner Lsu Health Shreveport-st Mary Medical Cent | Shreveport, LA | Hospital |
Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lsu Health Sciences Center Shreveport Faculty Group Practice | 4082902721 | 529 |
News Archive
One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the body.
Immigrants in the United States may be less likely to report a family history of cancer, which may lead to inadequate screening and cancer prevention strategies according to a new study.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
Boston Scientific Corporation today rebutted an article published in the journal HeartRhythm. The article reported a case summary of a patient who had been implanted subcutaneously with a Cognis cardiac resynchronization therapy defibrillator. The article suggested a weakened header bond was responsible for the abnormal sensing and pacing impedance experienced by the patient.
Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.
› Verified 5 days ago
Entity Name | Wk Bossier Orthopedic & Sports |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588715791 PECOS PAC ID: 6406951078 Enrollment ID: O20070411000016 |
News Archive
One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the body.
Immigrants in the United States may be less likely to report a family history of cancer, which may lead to inadequate screening and cancer prevention strategies according to a new study.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
Boston Scientific Corporation today rebutted an article published in the journal HeartRhythm. The article reported a case summary of a patient who had been implanted subcutaneously with a Cognis cardiac resynchronization therapy defibrillator. The article suggested a weakened header bond was responsible for the abnormal sensing and pacing impedance experienced by the patient.
Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.
› Verified 5 days ago
Entity Name | Lsu Health Sciences Center Shreveport Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013374222 PECOS PAC ID: 4082902721 Enrollment ID: O20161012000307 |
News Archive
One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the body.
Immigrants in the United States may be less likely to report a family history of cancer, which may lead to inadequate screening and cancer prevention strategies according to a new study.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
Boston Scientific Corporation today rebutted an article published in the journal HeartRhythm. The article reported a case summary of a patient who had been implanted subcutaneously with a Cognis cardiac resynchronization therapy defibrillator. The article suggested a weakened header bond was responsible for the abnormal sensing and pacing impedance experienced by the patient.
Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Richard M Harrell, MD 1455 E Bert Kouns Loop, Shreveport, LA 71105-5634 Ph: (318) 798-4623 | Dr Richard M Harrell, MD 1455 E Bert Kouns Loop, Shreveport, LA 71105-5634 Ph: (318) 798-4623 |
News Archive
One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the body.
Immigrants in the United States may be less likely to report a family history of cancer, which may lead to inadequate screening and cancer prevention strategies according to a new study.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
Boston Scientific Corporation today rebutted an article published in the journal HeartRhythm. The article reported a case summary of a patient who had been implanted subcutaneously with a Cognis cardiac resynchronization therapy defibrillator. The article suggested a weakened header bond was responsible for the abnormal sensing and pacing impedance experienced by the patient.
Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.
› Verified 5 days ago
Dr. Carlton Gregory Houtz, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Kouns Loop, Suite # 210, Shreveport, LA 71105 Phone: 318-798-4623 Fax: 318-798-4646 | |
Dr. Mario H Lobao Goncalves, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 Kings Hwy, Shreveport, LA 71103 Phone: 443-850-8427 Fax: 318-675-6181 | |
Powell Britain Auer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Kouns, Suite #210, Shreveport, LA 71105 Phone: 318-798-4623 Fax: 318-798-4646 | |
Benjamin Marcus Feibel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Kouns Industrial Loop Ste 210, Shreveport, LA 71105 Phone: 318-798-4623 | |
John Marshall Haynie, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Line Ave, Suite 100, Shreveport, LA 71101 Phone: 318-635-3052 Fax: 318-635-3072 | |
Margaret L Olmedo, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Orthopaedics, Shreveport, LA 71103 Phone: 318-675-7737 Fax: 318-675-5666 | |
Stephen L. Cox, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Line Ave, Suite 100, Shreveport, LA 71101 Phone: 318-635-3052 Fax: 318-635-3072 |